These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9741513)

  • 1. Triple drug therapy--what is next?
    Goldstein S
    J Am Coll Cardiol; 1998 Sep; 32(3):693-4. PubMed ID: 9741513
    [No Abstract]   [Full Text] [Related]  

  • 2. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme.
    Young JB; Gheorghiade M; Uretsky BF; Patterson JH; Adams KF
    J Am Coll Cardiol; 1998 Sep; 32(3):686-92. PubMed ID: 9741512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailored therapy to hemodynamic goals for advanced heart failure.
    Stevenson LW
    Eur J Heart Fail; 1999 Aug; 1(3):251-7. PubMed ID: 10935671
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of the efficacy and safety of ramipril and digoxin added to maintenance diuretic treatment in patients with chronic heart failure.
    Kholeif MA; Pringle S; Kesson E; Murray G; Kennedy JA; Lorimer AR; Stock JK; Brown JJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S180-3. PubMed ID: 1725036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin and angiotensin converting enzyme inhibitors in chronic heart failure.
    Gheorghiade M
    Can J Cardiol; 1990 Aug; 6 Suppl C():14C-17C. PubMed ID: 2205342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current role of digoxin in the treatment of heart failure.
    Smith JR; Gheorghiade M; Goldstein S
    Coron Artery Dis; 1993 Jan; 4(1):16-26. PubMed ID: 8269181
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic treatment of heart failure with standard drugs.
    Pitt B
    Curr Opin Cardiol; 1994 May; 9(3):289-94. PubMed ID: 8049587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should three-drug therapy be standard for heart failure?
    Harv Heart Lett; 1999 Jan; 9(5):5-6. PubMed ID: 9916561
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of heart failure. Digitalis, diuretic plus ACE inhibitor or more?].
    Becker H; Sigmund M
    Internist (Berl); 1995 Dec; 36(12):1117-23. PubMed ID: 8567216
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of lisinopril versus digoxin for congestive heart failure during maintenance diuretic therapy. The Lisinopril-Digoxin Study Group.
    Herlitz J
    Am J Cardiol; 1992 Oct; 70(10):84C-90C. PubMed ID: 1329479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
    Hou YP; Wu JL; Fan Q; Liu MB; Yin BL; Zhang L
    Clin Sci (Lond); 2007 Mar; 112(5):299-304. PubMed ID: 17020540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for chronic heart failure.
    Med Lett Drugs Ther; 1999 Jan; 41(1045):12-4. PubMed ID: 9949763
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of chronic heart failure with digitalis: are there still indications?].
    Strasser RH
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S32-6. PubMed ID: 10535044
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure.
    de Vries RJ; Dunselman PH; Chin Kon Sung UG; van Veldhuisen DJ; Corbeij HM; van Gilst WH; Lie KI
    Heart; 1996 Feb; 75(2):159-64. PubMed ID: 8673754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there an expanded role for digoxin in patients with heart failure and sinus rhythm? An antagonist viewpoint.
    Munger MA; Furniss SM
    Ann Pharmacother; 1997; 31(7-8):893-6. PubMed ID: 9220053
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug treatment for chronic heart failure with reduced ejection fraction].
    Rickenbacher P
    Ther Umsch; 2011 Feb; 68(2):71-9. PubMed ID: 21271537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
    Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
    N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose frusemide for cardiac failure.
    Waterer G; Donaldson M
    Lancet; 1995 Jul; 346(8969):254. PubMed ID: 7616829
    [No Abstract]   [Full Text] [Related]  

  • 20. Complications during enalapril and diuretic therapy for congestive cardiac failure.
    Mehta S; Vijayakumar M
    Indian J Pediatr; 2009 Sep; 76(9):963-4. PubMed ID: 19904515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.